Next Article in Journal
The Timing of Antidepressant Effects: A Comparison of Diverse Pharmacological and Somatic Treatments
Next Article in Special Issue
Structural Examination of 6-Methylsulphonylphenanthro- [9,10-C]-furan-1(3H)-one—A Rofecoxib Degradation Product
Previous Article in Journal
Spironolactone Plus Full-Dose ACE Inhibition in Patients with Idiopathic Membranous Nephropathy and Nephrotic Syndrome: Does It Really Work?
Pharmaceuticals 2010, 3(1), 10-18; doi:10.3390/ph3010010

Notes on Article Versions

Action Date Notes Link
article html file updated 18 January 2013 01:17 CET Original file -
article html file updated 21 January 2013 19:08 CET Update -
article html file updated 25 January 2013 20:38 CET Update -
article html file updated 28 January 2013 18:03 CET Update -
article html file updated 5 February 2013 20:26 CET Update -
article html file updated 6 February 2013 16:18 CET Update -
article xml file uploaded 28 April 2014 10:59 CEST Original file http://www.mdpi.com/1424-8247/3/1/10/xml
article html file updated 28 April 2014 10:59 CEST Update -
article html file updated 16 June 2015 07:51 CEST Update http://www.mdpi.com/1424-8247/3/1/10/html
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert